Abrdn PLC Xenon Pharmaceuticals Inc. Transaction History
Abrdn PLC
- $50.5 Billion
- Q1 2025
A detailed history of Abrdn PLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Abrdn PLC holds 404,154 shares of XENE stock, worth $12.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
404,154
Previous 283,899
42.36%
Holding current value
$12.9 Million
Previous $11.1 Million
21.85%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
69.9MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$183 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$146 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$121 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$106 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$98.5 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.99B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...